ImmuCell ICCC Stock
ImmuCell Price Chart
ImmuCell ICCC Financial and Trading Overview
| ImmuCell stock price | 5.02 USD |
| Previous Close | 5.51 USD |
| Open | 5.6 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 5.43 - 5.75 USD |
| 52 Week Range | 4.26 - 9.61 USD |
| Volume | 9.85K USD |
| Avg. Volume | 7.84K USD |
| Market Cap | 42.69M USD |
| Beta (5Y Monthly) | 0.665492 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.75 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ICCC Valuation Measures
| Enterprise Value | 52.81M USD |
| Trailing P/E | N/A |
| Forward P/E | -50.09091 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.6653588 |
| Price/Book (mrq) | 1.5158185 |
| Enterprise Value/Revenue | 3.298 |
| Enterprise Value/EBITDA | -21.349 |
Trading Information
ImmuCell Stock Price History
| Beta (5Y Monthly) | 0.665492 |
| 52-Week Change | -31.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.61 USD |
| 52 Week Low | 4.26 USD |
| 50-Day Moving Average | 5.03 USD |
| 200-Day Moving Average | 6.47 USD |
ICCC Share Statistics
| Avg. Volume (3 month) | 7.84K USD |
| Avg. Daily Volume (10-Days) | 8.74K USD |
| Shares Outstanding | 7.75M |
| Float | 5.53M |
| Short Ratio | 0.95 |
| % Held by Insiders | 28.65% |
| % Held by Institutions | 13.47% |
| Shares Short | 6.67K |
| Short % of Float | 0.11% |
| Short % of Shares Outstanding | 0.090% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -33.23% |
| Operating Margin (ttm) | -31.19% |
| Gross Margin | 31.06% |
| EBITDA Margin | -15.44% |
Management Effectiveness
| Return on Assets (ttm) | -6.95% |
| Return on Equity (ttm) | -17.29% |
Income Statement
| Revenue (ttm) | 16.01M USD |
| Revenue Per Share (ttm) | 2.07 USD |
| Quarterly Revenue Growth (yoy) | -42.60% |
| Gross Profit (ttm) | 7.65B USD |
| EBITDA | -2473721 USD |
| Net Income Avi to Common (ttm) | -5322145 USD |
| Diluted EPS (ttm) | -0.68 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.1M USD |
| Total Cash Per Share (mrq) | 0.4 USD |
| Total Debt (mrq) | 13.22M USD |
| Total Debt/Equity (mrq) | 46.95 USD |
| Current Ratio (mrq) | 3.191 |
| Book Value Per Share (mrq) | 3.635 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4944391 USD |
| Levered Free Cash Flow (ttm) | -6585390 USD |
Profile of ImmuCell
| Country | United States |
| State | ME |
| City | Portland |
| Address | 56 Evergreen Drive |
| ZIP | 04103 |
| Phone | 207 878 2770 |
| Website | https://immucell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 67 |
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Q&A For ImmuCell Stock
What is a current ICCC stock price?
ImmuCell ICCC stock price today per share is 5.02 USD.
How to purchase ImmuCell stock?
You can buy ICCC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImmuCell?
The stock symbol or ticker of ImmuCell is ICCC.
Which industry does the ImmuCell company belong to?
The ImmuCell industry is Biotechnology.
How many shares does ImmuCell have in circulation?
The max supply of ImmuCell shares is 7.75M.
What is ImmuCell Price to Earnings Ratio (PE Ratio)?
ImmuCell PE Ratio is now.
What was ImmuCell earnings per share over the trailing 12 months (TTM)?
ImmuCell EPS is -0.75 USD over the trailing 12 months.
Which sector does the ImmuCell company belong to?
The ImmuCell sector is Healthcare.
ImmuCell ICCC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}